Clinical Trial Update: Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and tolerability of BMS-754807 in adults with advanced or metastatic solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• BMS-754807 (BMS-754807)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Neoplasms, Solid Tumors | Phase 1 | Status: COMPLETED